Drug for further processing · DRUG FOR FURTHER PROCESSING
Ramelteon NDC 0591-2191
Ramelteon 8 mg/1 · Tablet · Actavis Pharma, Inc.
Unfinished product
This listing is a drug for further processing, not a finished drug product dispensed or administered to patients. It is not normally billed.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0591-2191-00 | 0059121910000591219100 | 69348 TABLET in 1 BOX (0591-2191-00)Marketed from 22-JUL-19 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Generic name (nonproprietary)
- ramelteon
- Active ingredients
- Ramelteon — 8 mg/1
- Dosage form
- Tablet
- Labeler
- Actavis Pharma, Inc.NDC labeler code 0591
- Product type
- Drug for further processing
- Marketing category
- Drug for further processing
- Marketing start
- Listing expires
- Identifiers
- Product ID 0591-2191_5f00542f-cea9-4b0b-8c85-870aca45cfdcSPL ID 5f00542f-cea9-4b0b-8c85-870aca45cfdc
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400591219100followed by a unit qualifier and the quantityPackage 00591-2191-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0591-2191
- What is NDC 0591-2191?
- 0591-2191 is the product NDC for Ramelteon, Ramelteon 8 mg/1 tablet, listed with the FDA by Actavis Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ramelteon.
- What is the active ingredient?
- Ramelteon.
- Who is the labeler?
- Actavis Pharma, Inc., NDC labeler code 0591. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ramelteon?
- 37 other product NDCs are listed under this name. See all Ramelteon NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ramelteon products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0593 | 80425-0593-01 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc. | 10135-838 | 10135-0838-0110135-0838-30 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | AvPAK | 50268-822 | 50268-0822-15 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2644 | 72162-2644-0172162-2644-03 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-023 | 85742-0023-2285742-0023-23 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4257 | 70518-4257-00 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | Major Pharmaceuticals | 0904-7494 | 00904-7494-06 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 59651-505 | 59651-0505-0159651-0505-30 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-2411 | 71335-2411-0171335-2411-02 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Asclemed USA, Inc. | 76420-880 | 76420-0880-0176420-0880-3076420-0880-60+1 more |